Cephalon to Bid for Australia's ChemGenex

FRAZER, Pennsylvania ( TheStreet) -- Cephalon ( CEPH) intends to make a takeover bid for ChemGenex Pharmaceuticals, the Australian biopharmaceutical company.

The total offer value for ChemGenex shares and listed ChemGenex options that Cephalon doesn't own is about $163 million, Cephalon said in a statement. The offer values all ChemGenex shares and options at about $231 million.

The takeover bid has the support of ChemGenex directors, who will recommend it to shareholders as long as a superior offer doesn't come along.

ChemGenex plans to file a new drug application with the Food and Drug Administration to sell Omapro, a treatment for chronic myeloid leukemia.

-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

More from Stocks

Bank Stocks Slump After Congress Greenlights Dodd-Frank Rollback

Bank Stocks Slump After Congress Greenlights Dodd-Frank Rollback

10 Questions for PayPal Ahead of Its Big Investor Day

10 Questions for PayPal Ahead of Its Big Investor Day

Stocks Tumble as Trump Comments Lead to Worries Over China Trade Talks

Stocks Tumble as Trump Comments Lead to Worries Over China Trade Talks

Tesla's Model 3 Is Far From Being for the Masses -- at Least For Now

Tesla's Model 3 Is Far From Being for the Masses -- at Least For Now

China Makes Good on Car Tariff Pledge, Tesla Wins Big

China Makes Good on Car Tariff Pledge, Tesla Wins Big